← Back to Search

Behavioral Intervention

UNTIRE App for Cancer-Related Fatigue

N/A
Waitlist Available
Led By Nina N Grenon, DNP, AOCN
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Summary

This trial is looking into if the Untire app can help manage CRF and if it's easy to use.

Who is the study for?
This trial is for adults over 18 with recurrent colorectal cancer who are currently undergoing treatment. Participants must own a smartphone or iPad, be able to read and speak English at a basic level, and experience fatigue related to their cancer.
What is being tested?
The study is testing the 'Untire' app, designed as a digital tool to help manage Cancer Related Fatigue (CRF) in patients with colorectal cancer. The research will assess if the app is user-friendly and effective in reducing fatigue.
What are the potential side effects?
Since this trial involves using an app for managing fatigue, there aren't typical medication side effects. However, users may experience frustration or stress if they find the technology challenging or if they do not see improvements in their fatigue.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Enrollment Rate
Secondary study objectives
CSQ-I Score
Other study objectives
The Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) Ratings

Trial Design

1Treatment groups
Experimental Treatment
Group I: UNTIRE AppExperimental Treatment1 Intervention
At baseline meeting participants will answer questionnaires and be introduced and instructed on self-managed use of Untire app treatment program. Participants will then have check in meetings assessing app usage and progress on weeks 4, 8 and 12 post baseline, then a final check-in 6 months post baseline.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,100 Previous Clinical Trials
353,037 Total Patients Enrolled
Nina N Grenon, DNP, AOCNPrincipal InvestigatorDana-Farber Cancer Institute

Media Library

UNTIRE App (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05584540 — N/A
Colorectal Cancer Research Study Groups: UNTIRE App
Colorectal Cancer Clinical Trial 2023: UNTIRE App Highlights & Side Effects. Trial Name: NCT05584540 — N/A
UNTIRE App (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05584540 — N/A
~40 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top